Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Dr. Wu Skincare Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,338	6,757	6,847	4,662	4,527	3,018
Market Cap Growth	-21.78%	-1.32%	46.86%	2.99%	50.00%	-33.99%
Enterprise Value	4,401	5,933	5,447	3,300	2,953	1,909
Last Close Price	118.50	138.86	131.37	83.11	73.93	41.22
PE Ratio	13.28	14.19	16.12	13.71	15.28	4.57
Forward PE	-	32.81	32.81	32.81	32.81	32.81
PS Ratio	4.32	5.44	6.02	5.03	4.09	3.95
PB Ratio	3.69	4.64	4.64	3.05	2.95	1.51
P/TBV Ratio	3.69	4.65	4.65	3.05	2.95	1.51
P/FCF Ratio	16.86	15.55	17.58	14.38	15.56	10.09
P/OCF Ratio	16.63	15.46	17.45	14.31	15.39	10.03
PEG Ratio	-	1.35	1.35	1.35	1.35	1.35
EV/Sales Ratio	3.56	4.78	4.79	3.56	2.67	2.50
EV/EBITDA Ratio	8.79	11.23	11.02	8.75	7.70	7.75
EV/EBIT Ratio	8.94	11.30	11.12	8.86	7.85	8.04
EV/FCF Ratio	13.89	13.66	13.98	10.18	10.15	6.38
Debt / Equity Ratio	0.03	0.03	0.00	0.01	0.02	0.02
Debt / EBITDA Ratio	0.08	0.09	0.01	0.04	0.07	0.14
Debt / FCF Ratio	0.13	0.11	0.01	0.05	0.09	0.11
Asset Turnover	0.65	0.71	0.64	0.51	0.54	0.35
Inventory Turnover	1.92	2.08	2.13	2.33	3.77	2.43
Quick Ratio	3.27	4.29	4.48	6.84	5.61	8.38
Current Ratio	3.89	5.01	5.62	7.39	6.06	8.84
Return on Equity (ROE)	27.02%	32.52%	28.28%	22.19%	16.77%	34.06%
Return on Assets (ROA)	16.25%	18.67%	17.26%	12.89%	11.49%	6.87%
Return on Capital (ROIC)	19.99%	22.01%	20.25%	15.00%	13.09%	7.49%
Return on Capital Employed (ROCE)	33.30%	35.10%	33.20%	23.80%	24.30%	11.70%
Earnings Yield	7.56%	7.05%	6.20%	7.29%	6.54%	21.90%
FCF Yield	5.93%	6.43%	5.69%	6.95%	6.43%	9.91%
Dividend Yield	9.28%	7.92%	7.61%	9.63%	17.88%	9.70%
Payout Ratio	122.76%	104.05%	106.06%	106.00%	261.85%	94.44%
Buyback Yield / Dilution	-0.32%	-0.19%	0.02%	0.02%	0.16%	-0.23%
Total Shareholder Return	9.04%	7.73%	7.63%	9.64%	18.04%	9.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.